Carl Ikeme is set to be offered a part on Nigeria mentor Gernot Rohr’s back-room staff in the wake of declaring his retirement aged 32.

The Nigerian goalkeeper was diagnosed of acute leukemia in July 2017, yet declared he was in “entire reduction” following “an extreme year and exceptional chemotherapy” in June.

While his retirement comes in the wake of counseling with therapeutic specialists, Nigeria Football Federation (NFF) says it intends to offer Ikeme a vocation when he finishes his treatment as a goalkeeper coach.

He was an encapsulation of total devotion, duty and enthusiastic enthusiasm in the division he played for the Super Eagles

NFF General Secretary, Mohammed Sanusi revelas: “The NFF will discover the assets to send Carl Ikeme on an instructing course, and a while later assimilate him into the specialized team of the Super Eagles.”

He added: “That is the slightest we can improve the situation such a devoted loyalist.

“He was an exemplification of total devotion, responsibility and energetic enthusiasm in the diversions that he played for the Super Eagles.

“The conditions of his retirement from the amusement are to some degree discouraging, even as we express gratitude toward God for his life,” Sanusi included.

Ikeme has turned into a much adored figure in Nigeria since venturing in as first decision goalkeeper following the retirement of the nation’s at that point chief and most-topped universal, Vincent Enyeama.

Conceived in Sutton Coldfield, qualified for both England and Nigeria, Ikeme settled on the Super Eagles and earned a call-up in August 2015.

He influenced his introduction in a 2017 Africa To measure of Nations qualifier against Tanzania in September 2015 and showed up for the three-time African champions, who regarded him at this current summer’s World Cup by naming him as their 24th squad part.

The Super Eagles were thumped out at the gathering stage in Russia and before the competition their mentor Gernot Rohr stated: “My greatest lament is the nonappearance of Carl.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here